GAMMA Investing LLC raised its position in shares of Hamilton Lane Incorporated (NASDAQ:HLNE - Free Report) by 24,544.3% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 136,776 shares of the company's stock after purchasing an additional 136,221 shares during the quarter. GAMMA Investing LLC owned 0.25% of Hamilton Lane worth $203,340,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also modified their holdings of the stock. Vanguard Group Inc. lifted its holdings in shares of Hamilton Lane by 28.4% in the 4th quarter. Vanguard Group Inc. now owns 3,901,933 shares of the company's stock valued at $577,681,000 after buying an additional 863,326 shares during the period. Invesco Ltd. lifted its holdings in shares of Hamilton Lane by 25.3% in the 4th quarter. Invesco Ltd. now owns 1,923,253 shares of the company's stock valued at $284,738,000 after buying an additional 388,019 shares during the period. Price T Rowe Associates Inc. MD lifted its holdings in shares of Hamilton Lane by 229.7% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 1,292,266 shares of the company's stock valued at $191,321,000 after buying an additional 900,283 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Hamilton Lane by 4.1% in the 4th quarter. Geode Capital Management LLC now owns 1,149,928 shares of the company's stock valued at $170,280,000 after buying an additional 44,865 shares during the period. Finally, T. Rowe Price Investment Management Inc. lifted its holdings in shares of Hamilton Lane by 10.0% in the 4th quarter. T. Rowe Price Investment Management Inc. now owns 780,363 shares of the company's stock valued at $115,533,000 after buying an additional 70,976 shares during the period. Institutional investors and hedge funds own 97.40% of the company's stock.
Hamilton Lane Price Performance
NASDAQ:HLNE traded up $1.55 during trading hours on Thursday, hitting $150.63. 566,672 shares of the stock were exchanged, compared to its average volume of 459,577. Hamilton Lane Incorporated has a 52-week low of $114.85 and a 52-week high of $203.72. The firm's fifty day moving average price is $152.70 and its 200 day moving average price is $157.19. The company has a current ratio of 4.19, a quick ratio of 4.19 and a debt-to-equity ratio of 0.34. The company has a market cap of $8.35 billion, a P/E ratio of 27.79 and a beta of 1.31.
Hamilton Lane (NASDAQ:HLNE - Get Free Report) last posted its quarterly earnings data on Thursday, May 29th. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $1.20 by $0.01. Hamilton Lane had a return on equity of 36.69% and a net margin of 31.12%. The company had revenue of $197.97 million during the quarter, compared to analyst estimates of $165.49 million. During the same period in the previous year, the business earned $1.38 EPS. Hamilton Lane's quarterly revenue was up 12.1% on a year-over-year basis. As a group, equities research analysts anticipate that Hamilton Lane Incorporated will post 4.97 EPS for the current fiscal year.
Hamilton Lane Increases Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Monday, July 7th. Shareholders of record on Friday, June 20th will be paid a dividend of $0.54 per share. This is a positive change from Hamilton Lane's previous quarterly dividend of $0.49. This represents a $2.16 annualized dividend and a yield of 1.43%. The ex-dividend date of this dividend is Friday, June 20th. Hamilton Lane's payout ratio is 40.07%.
Analyst Ratings Changes
HLNE has been the subject of several analyst reports. Keefe, Bruyette & Woods decreased their price objective on Hamilton Lane from $162.00 to $155.00 and set a "market perform" rating for the company in a report on Monday. Oppenheimer lowered Hamilton Lane from an "outperform" rating to a "market perform" rating in a research note on Thursday, May 15th. JPMorgan Chase & Co. cut their price target on Hamilton Lane from $176.00 to $167.00 and set a "neutral" rating for the company in a research note on Tuesday, April 29th. Wells Fargo & Company cut their price target on Hamilton Lane from $166.00 to $161.00 and set an "equal weight" rating for the company in a research note on Friday, May 30th. Finally, Morgan Stanley cut their price target on Hamilton Lane from $190.00 to $157.00 and set an "equal weight" rating for the company in a research note on Monday, April 14th. One investment analyst has rated the stock with a sell rating and six have given a hold rating to the company. According to MarketBeat.com, the company has an average rating of "Hold" and a consensus target price of $164.29.
View Our Latest Analysis on Hamilton Lane
Hamilton Lane Profile
(
Free Report)
Hamilton Lane Incorporated is a private equity firm specializing in early venture, emerging growth, turnaround, middle market, mature, mid-venture, bridge, buyout, distressed/vulture, loan, mezzanine in growth capital companies. It prefers to invest in energy, industrials, consumer discretionary, health care, real estate, information technology, utilities, and consumer services.
Further Reading

Before you consider Hamilton Lane, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hamilton Lane wasn't on the list.
While Hamilton Lane currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.
Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.